Brief: AC Immune Positive Interim Phase 2 Data On ACI-7104.056 Support Potential Slowing Of Progression Of Parkinson’s Disease

AC Immune AG

11/12/2025 12:39

Dec 11 (Reuters) - AC Immune SA ACIU.O:

AC IMMUNE POSITIVE INTERIM PHASE 2 DATA ON ACI-7104.056 SUPPORT POTENTIAL SLOWING OF PROGRESSION OF PARKINSON’S DISEASE

AC IMMUNE SA - IMMUNOTHERAPY COULD SLOW PARKINSON'S PROGRESSION

AC IMMUNE SA - ACI-7104.056 SHOWS CLEAR SAFETY PROFILE

AC IMMUNE SA - TARGETS MET FOR IMMUNOGENICITY AND PHARMACODYNAMICS

AC IMMUNE SA - ACI-7105.056 SAFE AND WELL-TOLERATED

Source text: ID:nGNXc2FcSb

Further company coverage: ACIU.O

 ((Reuters.Briefs@thomsonreuters.com;))